1. 1238TiPA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. (23rd October 2018) Authors: Jabulowsky, R A; Loquai, C; Derhovanessian, E; Mitzel-Rink, H; Utikal, J; Hassel, J; Kaufmann, R; Pinter, A; Diken, M; Gold, M; Heesen, L; Schreeb, K H; Schwarck-Kokarakis, D; Kreiter, S; Gaiser, M R; Jäger, D; Grabbe, S; Türeci, Ö; Sahin, U Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial. (11th October 2018) Authors: Gaiser, M R; Lorenzen, S; Merx, K; Trojan, J; Ocvirk, J; Ettrich, T J; Al-Batran, S -E; Schulz, H; Homann, N; Feustel, H -P; Schatz, M; Kripp, M; Schulte, N; Heeger, S; Vlassak, S; Koch, W; Hofheinz, R -D Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗